Ampicillin plus Ceftriaxone for High-Level Aminoglycoside-Resistant Enterococcus faecalis Endocarditis

  1. Joan Gavaldá, MD, PhD;
  2. Oscar Len, MD;
  3. Benito Almirante, MD; and
  4. Albert Pahissa, MD
  1. From Hospital Vall d'Hebron, 08035 Barcelona, Spain.

    IN RESPONSE:

    We read with interest the letter by Dr. Singh regarding our article. First, we would like to clarify that the cure rate for HLAR E. faecalis endocarditis was 71.4%, far greater than the best cure rate reached with a cell-wall–susceptible agent alone or in combination with other therapy. After careful review of our article, we …

    This 100-word excerpt has been provided in the absence of an abstract.

    Summary for Patients

    | Table of Contents
    Most Read Most Read
    Most Commented Most Commented On
    Annals in the News Annals in the News
    Clinical Trials Clinical Trials
    Comparative Effectiveness Comparative Effectiveness
    Hospital Medicine Hospital Medicine
    • Advertisement
    • Advertisement